Results of Treatment for Metastatic Osteosarcoma With Neoadjuvant Chemotherapy and Surgery
Authors:
- Edward Y. ChengECEdward Y. Cheng
- Denis R. ClohisyDCDenis R. Clohisy
- John PerentesisJPJohn Perentesis
- Carlos ManivelCMCarlos Manivel
- Chap T. LeCLChap T. Le
- 1 April 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Orthopaedics and Related Research
- Vol. 397 (397) , 240-247
Abstract
The purpose of the current study was to define the survival outcome variables for the 85 patients with Stage IIB osteosarcoma treated with neoadjuvant chemotherapy at the authors’ institution from 1982 to 1997. A minimum 4-year followup or death was a requisite for inclusion. Forty-three patients were relapse-free survivors and 14 had no evidence of disease at followup for an overall survival of 67%. Twenty-nine patients had thoracotomy and nine have no evidence of disease with a minimum 4-year followup from last thoracotomy. The mean time to metastasis after diagnosis for patients presenting with Stage IIB disease was 12.8 months. There was no difference in the survival for any of the three chemotherapy protocols, used during the 15 years included in this analysis. There was a significant relation between length of time to relapse and survival. For each additional year without relapse, there is an 18% increase in chance of survival. In patients who were treated with thoracotomy, the number of metastatic nodules was a significant predictor of survival; specifically, each nodule increased the risk of death by 43%. A favorable outcome in this cohort of patients is related to the length of time between initiation of therapy and diagnosis of metastasis, and the number of metastatic foci.Keywords
This publication has 43 references indexed in Scilit:
- UNUSUAL LATE EXTRAPULMONARY METASTASIS IN OSTEOSARCOMAPediatric Hematology and Oncology, 1999
- Neoadjuvant Chemotherapy for Extremity Osteosarcoma: Preliminary Results of the Rizzoli's 4th StudyActa Oncologica, 1998
- VIDEO‐ASSISTED THORACOSCOPIC WEDGE RESECTIONS OF PULMONARY METASTATIC OSTEOSARCOMA: SHOULD IT BE PERFORMED?Anz Journal of Surgery, 1995
- Pulmonary metastases in children: Results of surgical treatmentJournal of Pediatric Surgery, 1988
- Results and prognostic factors after resection of pulmonary metastasesEuropean Journal of Cardio-Thoracic Surgery, 1988
- Combined chemotherapy and surgery for pulmonary metastases from osteogenic sarcoma Results of 10 years experienceEuropean Journal of Cardio-Thoracic Surgery, 1988
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986
- Treatment of unresectable or metastatic osteosarcoma with cisplatin or cisplatin–doxorubicinCancer, 1985
- Transmedullary amputation and resection of metastases in combined therapy of osteosarcomaJournal of Pediatric Surgery, 1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958